| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’
|
Schöffski, Patrick
|
|
|
134 |
C |
p. 62-74
|
article
|
| 2 |
Arterial thrombosis and coronavirus disease 2019 in a patient with cancer
|
Nassabein, Rami
|
|
|
134 |
C |
p. 1-2
|
article
|
| 3 |
Comment on ‘Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey’ by Alice Indini et al.
|
Bongiovanni, Alberto
|
|
|
134 |
C |
p. 3-5
|
article
|
| 4 |
Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study
|
Chen, Shiguang
|
|
|
134 |
C |
p. 90-98
|
article
|
| 5 |
Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990–2017
|
Reedijk, Ardine M.J.
|
|
|
134 |
C |
p. 115-126
|
article
|
| 6 |
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study
|
Nigro, Olga
|
|
|
134 |
C |
p. 19-28
|
article
|
| 7 |
Letter responds to the comment in ‘immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty’
|
Michot, Jean-Marie
|
|
|
134 |
C |
p. 60-61
|
article
|
| 8 |
Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion
|
Mathew, Ashwathy Susan
|
|
|
134 |
C |
p. 41-51
|
article
|
| 9 |
Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
|
Amit, Moran
|
|
|
134 |
C |
p. 86-89
|
article
|
| 10 |
Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer
|
Zhou, Tie
|
|
|
134 |
C |
p. 29-40
|
article
|
| 11 |
Risk of coronavirus disease 2019 in patients treated for cancer: An immune response–based hypothesis
|
Roberto, Michela
|
|
|
134 |
C |
p. 6-8
|
article
|
| 12 |
Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography
|
Sadate, Alexandre
|
|
|
134 |
C |
p. 107-114
|
article
|
| 13 |
The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients
|
Zamani, Martin
|
|
|
134 |
C |
p. 52-59
|
article
|
| 14 |
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
|
Dubsky, Peter C.
|
|
|
134 |
C |
p. 99-106
|
article
|
| 15 |
The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node–positive melanoma without the need for completion lymph node dissection
|
Verver, Daniëlle
|
|
|
134 |
C |
p. 9-18
|
article
|
| 16 |
Venous thromboembolic events in patients with brain metastases: the PICOS score
|
Wolpert, Fabian
|
|
|
134 |
C |
p. 75-85
|
article
|
Journal description